US20160003847A1 - Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive Cancers - Google Patents

Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive Cancers Download PDF

Info

Publication number
US20160003847A1
US20160003847A1 US14/798,379 US201514798379A US2016003847A1 US 20160003847 A1 US20160003847 A1 US 20160003847A1 US 201514798379 A US201514798379 A US 201514798379A US 2016003847 A1 US2016003847 A1 US 2016003847A1
Authority
US
United States
Prior art keywords
antibody
cancer
antibodies
cells
pancreatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/798,379
Inventor
Maureen Ryan
Maria Leia Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seattle Genetics Inc
Original Assignee
Seattle Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US4445708P priority Critical
Priority to PCT/US2009/040275 priority patent/WO2009126934A2/en
Priority to US93719010A priority
Application filed by Seattle Genetics Inc filed Critical Seattle Genetics Inc
Priority to US14/798,379 priority patent/US20160003847A1/en
Publication of US20160003847A1 publication Critical patent/US20160003847A1/en
Abandoned legal-status Critical Current

Links